Replies to post #13089 on Innovus Pharmaceuticals Inc. (fka INNV)

[jtaylor68]

I agree, this is going to be INNV's strongest year. I expect Fluticare sales to be on the lower end for Q1 though, but this will be attributable to the tight marketing budget and not to Fluticare being poorly received by the market.

Now waiting for Fluticare launch in retail stores. This should elevate the share price by a few cents if it happens in synergy with the current upwards trend.